Sfoglia per AUTORE
CANU L
Collezione ASL Torino 4
Items : 3
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. in ESMO open / ESMO Open. 2022 Apr;7(2):100422. doi: 10.1016/j.esmoop.2022.100422. Epub 2022 Mar 7.
2022
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 4
AOU San Luigi di Orbassano
Sigala S; Tiberio GAM; Terzolo M; Canu L; Turla A; Gianoncelli A; Ferrari VD; Zamparini M; Abate A; Ambrosini R; Cosentini D; Grisanti S; Laganà M; Berruti A;
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study in Journal of Clinical Oncology
2022
ASL Torino 4
ASL Torino 4
Berruti A; Fassnacht M; Libè R; Lacroix A; Kastelan D; Haak H; Arlt W; Decoudier B; Lasolle H; Bancos I; Quinkler M; Barisson Villares Fragoso MC; Canu L; Puglisi S; Bourdeau I; Baudin E; Berchialla P; Beuschlein F; Bertherat J; Terzolo M;
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. in European journal of endocrinology / Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.
2021
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 4
AOU San Luigi di Orbassano
Cosentini D; Berhane S; Altieri B; Elhassan YS; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL;